• Worked on Pharmaceutical, Financial, and Research Dashboard, cover the US pharmaceuticals financials and R&D aspects, analyze US Pharmaceuticals product pipeline, such as the upcoming drugs and their impact on multiple therapeutic areas, and manage the pharmaceutical companies’ in-depth research on different portfolios.
• Comprehensive coverage of US Pharmaceutical and Medical Devices segments of Multinational companies, such as Abbott, AstraZeneca, Amgen, Biogen, GSK, Pfizer, Wyeth, JNJ, Siemens, General Electric, Medtronic, Novartis, and Abbott; the devices comprise CT scans, MRI scans, Laboratory Equipment, Cardiology products, Vision care, Vascular products, Imaging, Mammography, radiation oncology, ultrasound, Advanced molecular imaging, etc. Moreover, maintenance of the companies’ full database, along with financials, and interaction with the North American Clients with regard to the aforementioned companies
• Worked on the development of Pharmaceutical Module, which includes the US pharmaceutical companies’ comprehensive segment-wise details, such as financials, drugs, patents, approvals, etc.
• Working on research on multiple therapeutic segments research such as oncology, immunology, pathology, etc and editing of the articles and research analysis.
• Monitor changes in the pharmaceutical companies’ financial status on daily and weekly basis, US pharma industry stocks, and review of drugs to be launch, pending FDA approvals, clinical trial, etc. This also extends to these companies’ mergers and acquisitions and related sell-side reports
• Providing Customer support to North American clients (Hedge funds, Financial managers, etc.) specifically in relation to US Pharmaceutical sector
• Written analysis pieces on websites www.bidnessetc.com, http://www.businessfinancenews.com, www.forbes.com